What does this research mean for the field?

Siglec15 is a critical regulator of fibrosarcoma progression and radiosensitivity. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This study investigates the role of Siglec15 in fibrosarcoma progression and its impact on radiosensitivity.

March 12, 2026ESMO rare cancers.0 citationsOpen Access

216P Siglec15 as a critical regulator of fibrosarcoma progression and radiosensitivity

JWJ. wangQingdao University TGTingting GaoDalian Medical University BLB. liShandong First Medical University

Key Points

This study investigates the role of Siglec15 in fibrosarcoma progression and its impact on radiosensitivity.
Analyzed the performance of ChatGPT-5.1 on hypothetical sarcoma cases
Evaluated the effectiveness of different prompting techniques
Assessed the creation of custom GPTs for improved oncologist communication
ChatGPT-5.1 showed strong performance across 25 sarcoma scenarios
Effective prompting significantly improved information clarity and relevance
Custom GPTs may enhance the accuracy and timeliness of responses for oncologists

Abstract

Conclusions: ChatGPT-5.1 performed well across 25 hypothetical sarcoma cases.Effective prompting (providing a role and expected format for responses) improves IC and EV.Creation of custom GPTs for sarcoma may further improve the ability of LLMs to provide accurate, timely information for oncologists.

Ask AI

Helpful

Bookmark

View Full Paper